Cancer Chemotherapy by Infusion

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Springer Netherlands

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-94-009-3193-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood supply and vascular pattern of induced primary hepatic carcinoma in rats. A microangiographic and histologic investigation.

  2009cited by this paper
• Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.

  2009cited by this paper
• [Chemotherapy of cancer of the esophagus].

  1989cited by this paper
• Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer

  1987cited by this paper
• BCG in management of superficial bladder cancer.

  1987cited by this paper
• Doxorubicin/vinblastine and doxorubicin/cyclophosphamide combination chemotherapy by continuous infusion

  1986cited by this paper
• Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

  1986cited by this paper
• Implantable infusion pumps

  1986cited by this paper
• Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.

  1986cited by this paper
• Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer.

  1986cited by this paper
• Long-term venous access using a subcutaneous implantable drug delivery system.

  1986cited by this paper
• Continuous infusion chemotherapy.

  1986cited by this paper
• Vinblastine plus cisplatin in advanced non-small cell lung cancer: lack of advantage for vinblastine infusion schedule.

  1986cited by this paper
• Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries

  1986cited by this paper
• The activity of a single‐agent 5‐fluorouracil infusion in advanced and recurrent head and neck cancer

  1986cited by this paper
• Complication of a Hickman catheter. Cutaneous erosion of the Dacron cuff.

  1985cited by this paper
• Future directions in the chemotherapy of head and neck cancer.

  1985cited by this paper
• The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.

  1985cited by this paper
• ACCURACY OF COMPUTERIZED TOMOGRAPHY IN DETERMINING HEPATIC TUMOR SIZE IN PATIENTS RECEIVING LIVER TRANSPLANTATION OR RESECTION

  1985cited by this paper
• Peak vinblastine concentration as a montior of non hematologic toxicity in patients with testicular cancer

  1985cited by this paper
• Correlation between response to cis-platinum combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

  1985cited by this paper
• Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.

  1985cited by this paper
• Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.

  1985cited by this paper
• Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion.

  1985cited by this paper
• Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon.

  1985cited by this paper
• Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases.

  1985cited by this paper
• Squamous cell carcinoma of the esophagus. Treatment by combined vincristine‐methotrexate plus folinic acid rescue and cisplatin before radiotherapy

  1985cited by this paper
• Improved complete response rate and survival in advanced head and neck cancer after three‐course induction therapy with 120‐hour 5‐FU infusion and cisplatin

  1985cited by this paper
• Intrapericardial Instillation of Cisplatin in a Patient with a Large Malignant Effusion

  1985cited by this paper
• Adjuvant systemic therapy for resectable breast cancer.

  1985cited by this paper
• Cellular and clinical pharmacology of low-dose ara-C.

  1985cited by this paper
• Phase II trial of diaziquone in advanced upper aerodigestive cancer.

  1985cited by this paper
• Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.

  1985cited by this paper
• Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage.

  1985cited by this paper
• Chemotherapy of extragonadal germ cell tumors.

  1985cited by this paper
• A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma

  1985cited by this paper
• Gastric cancer: overview of current therapies.

  1985cited by this paper
• Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.

  1985cited by this paper
• Clinical pharmacology of low-dose cytosine arabinoside.

  1985cited by this paper
• Streptozotocin for metastatic malignant melanoma.

  1985cited by this paper
• Doxorubicin‐induced congestive heart failure in adults

  1985cited by this paper
• Phase I trial of an implanted battery-powered, programmable drug delivery system for continuous doxorubicin administration.

  1985cited by this paper
• Treatment of leukemia with low-dose ara-C: a study of 160 cases.

  1985cited by this paper
• High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.

  1985cited by this paper
• Anterior chemotherapy in esophageal cancer

  1985cited by this paper
• Complications and management of implanted venous access catheters.

  1985cited by this paper
• The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin.

  1985cited by this paper
• Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.

  1985cited by this paper
• Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study

  1985cited by this paper
• Central venous catheter sepsis.

  1985cited by this paper
• Results from use of 826 vascular access devices in cancer patients

  1985cited by this paper
• Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.

  1985cited by this paper
• Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer.

  1985cited by this paper
• Control of spasticity by implantable continuous flow morphine pump.

  1985cited by this paper
• Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.

  1985cited by this paper
• Neoadjuvant (preoperative) chemotherapy for breast cancer

  1985cited by this paper
• Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.

  1985cited by this paper
• Mitomycin: ten years after approval for marketing.

  1985cited by this paper
• 5‐fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study

  1985cited by this paper
• Isolation perfusion for malignant melanoma of the extremity: a review.

  1985cited by this paper
• Evaluation of silicone elastomer catheters for long-term intravenous chemotherapy.

  1985cited by this paper
• Doxorubicin plus cisplatin in the treatment of apudomas

  1985cited by this paper
• Low‐dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8‐trisomy: in vitro and in vivo evidence for normal haematopoietic recovery

  1985cited by this paper
• Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.

  1985cited by this paper
• Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.

  1985cited by this paper
• A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.

  1985cited by this paper
• Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy.

  1985cited by this paper
• High-dose cisplatin with sodium thiosulfate protection.

  1985cited by this paper
• Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver.

  1985cited by this paper
• High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

  1985cited by this paper
• The use of a vasoconstrictor to improve tumour blood flow in intra‐arterial chemotherapy: preliminary report

  1985cited by this paper
• The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ.

  1985cited by this paper
• A totally implanted venous access system for the delivery of chemotherapy

  1985cited by this paper
• A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy.

  1985cited by this paper
• Effective multimodality treatment for advanced epidermoid carcinoma of the female genital tract.

  1985cited by this paper
• Intensive timed chemotherapy for 51 acute myeloid leukemia patients with poor prognosis.

  1985cited by this paper
• Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.

  1985cited by this paper
• Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.

  1985cited by this paper
• Hickman catheter separation.

  1985cited by this paper
• Adjuvant intrahepatic chemotherapy with mitomycin and 5-FU combined with hepatic irradiation in high-risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study.

  1985cited by this paper
• Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

  1985cited by this paper
• Combined thiotepa and mitomycin C instillation therapy for low‐grade superficial bladder tumor

  1985cited by this paper
• Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate.

  1985cited by this paper
• Infectious peritonitis in patients receiving intraperitoneal chemotherapy.

  1985cited by this paper
• Drug extravasation as a complication of venous access ports.

  1985cited by this paper
• Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabine.

  1985cited by this paper
• Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

  1985cited by this paper
• Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.

  1985cited by this paper
• Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.

  1985cited by this paper
• Surgical Aspects of Intra-Arterial Chemotherapy of Outpatients with Head and Neck Cancer

  1985cited by this paper
• Adjuvant therapy in rectal cancer: a protocol proposal.

  1985cited by this paper
• Adriamycin, cyclophosphamide, and etoposide (VP‐16–213) in extensive‐stage small cell lung cancer

  1984cited by this paper
• Bleomycin-Adriamycin-Cisplatin Combination Chemotherapy in the Treatment of Primary Advanced and Recurrent Cervical Carcinoma

  1984cited by this paper
• Pulmonary embolism secondary to venous thrombosis of the arm.

  1984cited by this paper
• Hepatic artery ligation for liver metastasis in colorectal carcinoma

  1984cited by this paper
• Plasma pharmacokinetics and tissue distribution of thiotepa in mice.

  1984cited by this paper
• Teniposide (VM26) disposition in children with leukemia.

  1984cited by this paper
• Continuous infusion versus intermittent bolus injection of bleomycin in a human embryonal testicular cancer xenograft.

  1984cited by this paper
• Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.

  1984cited by this paper
• Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas.

  1984cited by this paper

• PHARMACEUTICAL INTERACTION BETWEEN CYTOSTATIC DRUGS AND NACL 0,9% AND DEXTROSE 5% INFUSION

  2014cites this paper
• Wirkstoffeliminationssysteme und Induktionschemotherapie

  2013cites this paper
• Outcomes of Treatment for Squamous Cell Carcinoma Originating as a Marjolin's Ulcer

  2012cites this paper
• Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer

  2012cites this paper
• Drug Removal Systems and Induction Chemotherapy

  2011cites this paper
• Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin

  2011cites this paper
• Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study

  2009cites this paper
• Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience

  2009cites this paper
• Regional chemotherapy: overview.

  2008cites this paper
• Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.

  2007cites this paper
• Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.

  2007cites this paper
• Drug compatibility with new polyolefin infusion solution containers.

  2006cites this paper
• Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer.

  2006cites this paper
• Ifosfamide treatment as a 10-day continuous intravenous infusion

  2005cites this paper
• Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium.

  2005cites this paper
• Alteration of the Pharmacokinetics of COL-3, a Matrix Metalloproteinase Inhibitor, Due to Acute Gastrointestinal Toxicity of Doxorubicin

  2005cites this paper
• Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group.

  2003cites this paper
• Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials.

  2002cites this paper
• A Phase II Study of a Daily ×4 Schedule of Vinorelbine Plus Cisplatin for Advanced Non-small Cell Lung Cancer

  2000cites this paper
• Regional Chemotherapy of Cancer of the Pancreas

  2000cites this paper
• National Cancer Institute Experience with Regional Therapy for Unresectable Primary and Metastatic Cancer of the Liver or Peritoneal Cavity

  2000cites this paper
• Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer

  1999cites this paper
• Influence of the schedule of exposure on the cytotoxic effect of melphalan on human 8226 and A2780 cells.

  1999cites this paper
• Neoadjuvant Chemotherapy with FLEP Regimen for Incurable Gastric Cancer

  1999cites this paper
• Radiotherapy and concurrent continuous infusion of cisplatin with adjuvant surgery in nonresectable Stage III lung carcinoma: short- and long-term results of a Phase II study.

  1999cites this paper
• Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

  1999cites this paper
• Control of Liver Metastasis by Intrahepatic Chemotherapy with Angiotensin II

  1999cites this paper
• Chemotherapy and chemoradiotherapy for esophageal cancer.

  1998cites this paper
• Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer.

  1997cites this paper
• Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study.

  1997cites this paper
• Irradiation Plus 5-Fluorouracil: Cellular Mechanisms of Action and Treatment Schedules.

  1997cites this paper
• Liposomal drug delivery.

  1996cites this paper
• Elimination of dose limiting toxicities of cisplatin, 5‐fluorouracil, and leucovorin using a weekly 24‐hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

  1996cites this paper
• Effect of Catecholamines on hydroxyl radical formation by Bleomycin‐iron (III) + H2O2

  1996cites this paper
• Expression de la posologie des médicaments anticancéreux

  1996cites this paper
• Implications for cancer chemotherapy

  1995cites this paper
• A pharmacokinetic-pharmacodynamic study on carboplatin administered in prolonged continuous infusion regimens with synchronous radiotherapy

  1995cites this paper
• Chronobiology. Implications for cancer chemotherapy.

  1995cites this paper
• Ambulatory infusion pumps: application to oncology.

  1995cites this paper
• Luminescence from the bleomycin + iron (II) + O2 and bleomycin + iron (III) + H2O2 systems

  1995cites this paper
• Testicular cancer treated in a minor general oncology department.

  1995cites this paper
• Fluoropyrimidine cancer chronotherapy

  1994cites this paper
• Individual dose adaptation of anticancer drugs.

  1994cites this paper
• Spontaneous or imposed circadian changes in plasma concentrations of 5‐fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer

  1994cites this paper
• The clinical rationale for S-phase radiosensitization in human tumors.

  1993cites this paper
• Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer

  1993cites this paper
• Hematologic effects of chemotherapy.

  1992cites this paper
• Radiosensitization of cultured human colon adenocarcinoma cells by 5-fluorouracil: effects on cell survival, DNA repair, and cell recovery.

  1992cites this paper
• Chemotherapeutische Strategien beim kolorektalen Karzinom — Eine Übersicht

  1992cites this paper
• Long-term central venous catheters: issues for care.

  1992cites this paper
• Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

  1992cites this paper
• Protracted (Continuous 5-Fluorouracil) Infusion with Concomitant Radiation Therapy: Indications and Results

  1991cites this paper
• Combination Chemotherapy by Infusion in Solid Tumors

  1991cites this paper
• Combination Chemotherapy by Infusion in Hematological Malignancies

  1991cites this paper
• 5-Fluorouracil by protracted venous infusion: a review of recent clinical studies.

  1991cites this paper
• Combined intravenous and intra-arterial chemotherapy using Cisplatin, Fluorouracil, Mitomycin C and Etoposide in the treatment of hepatic metastasis

  1991cites this paper
• Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.

  1991cites this paper
• Admixtures of Chemotherapy Agents by Continuous Infusion

  1991cites this paper
• Technical Developments in the Delivery of Antineoplastic Agents

  1990cites this paper
• Pharmacodynamics in cancer therapy.

  1990cites this paper
• Determination of diastolic function by radionuclide ventriculography.

  1990cites this paper
• Chemoembolisation in Regional Chemotherapy

  1989cites this paper
• The role of chemotherapy in the treatment of squamous cell tumors of the esophagus.

  1989cites this paper
• Renal cell carcinoma.

  1988cites this paper
• Clinical Pharmacokinetics of Doxorubicin

  1988cites this paper
• Regional and systemic chemotherapy for colorectal metastases to the liver

  1987cites this paper